IDEXX Laboratories Announces Increase in Share Repurchase Program

Details

announced that its Board of Directors authorized an increase of up to five million additional shares for its ongoing share repurchase program, in addition to the 1.3 million shares remaining under the program as of the same date. The share repurchase program has no specified expiration date and may be suspended or discontinued at any time. The authorization is described in a press release issued on December 9, 2024.

Items reported

Exhibits (1)

About Idexx Laboratories, Inc.

Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.